ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Trade (domestic/foreign) TRD

Free Trade Agreements-Trans Pacific Partnership, Anti-Counterfeiting Trade Agreement (ACTA), Generic Drugs

Contacted: Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Federal Trade Commission (FTC); Food & Drug Administration (FDA); SENATE; Congressional Budget Office (CBO)

Copyright/Patent/Trademark CPT

Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R.1366 - Stop Oxy Abuse Act of 2013 S.214 - Preserve Access to Affordable Generics Act S.504 - Fair And Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013

Contacted: HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Federal Trade Commission (FTC); SENATE; Congressional Budget Office (CBO); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA)

Bills named: S. 214 (113th), S. 504 (113th), H.R. 1285 (113th), S. 621 (113th), H.R. 1366 (113th)

Medicare/Medicaid MMM

FY 2014 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and Generic DrugsH.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023

Contacted: HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Federal Trade Commission (FTC); Food & Drug Administration (FDA); SENATE; Medicare Payment Advisory Commission (MedPAC); Congressional Budget Office (CBO)

Bills named: H.Con.Res. 25 (113th)

Budget/Appropriations BUD

Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY14 BudgetH.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Congressional Budget Office (CBO); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Federal Trade Commission (FTC); Office of Management & Budget (OMB)

Bills named: H.Con.Res. 25 (113th)

Pharmacy PHA

FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, and Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R.1366 -Stop Oxy Abuse Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 S.214 - Preserve Access to Affordable Generics Act S.504 - Fair And Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013

Contacted: Federal Trade Commission (FTC); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE; Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Congressional Budget Office (CBO)

Bills named: S. 214 (113th), H.R. 933 (113th), S. 621 (113th), H.R. 1366 (113th), H.R. 1285 (113th), S. 504 (113th), H.Con.Res. 25 (113th)